In this study, we presented the findings demonstrating the superior cytotoxicity of PE CAR-T cells against CD19 + PDL1 + tumor cells, accompanied by a reduction in cytokine release both in vitro and in vivo. The gene discussed is CD19; the disease is neoplasm.